e-Drug3D

1792

SUGAMMADEX


INN
SUGAMMADEX

cas 343306-71-8
CLASS

VARIOUS
CHELATOR
REVERSAL OF NEUROMUSCULAR BLOCKADE INDUCED BY ROCURONIUM BROMIDE AND VECURONIUM BROMIDE IN ADULTS UNDERGOING SURGERY

ROUTE (list)

INTRAVENOUS INJECTION

ATC code

V03AB35

PK parameters

VD 12.5 LITER
Cl 5.2 LITER / HOUR
PPB 0 PERCENT
t1/2 2 HOUR

Target

-

DrugCentral

Unknown

Download SDF file gamma-Cyclodextrin, 6A,6B,6C,6D,6E,6F,6G,6H-octakis-S-(2-carboxyethyl)-6A,6B,6C,6D,6E,6F,6G,6H-octathio-

Formula:
C72H112O48S8

Calculated chemical properties:

MW 1994.11
NB_atoms 128
XLogP -18.36
PSA 746.984
NB_HD 16
NB_HA 48
fsp3 0.89
Lipinski(0=no;1=yes) 0

FDA
NDA 022225 (label) INN (SUGAMMADEX SODIUM) BRIDION (MSD SUB MERCK) APPROVAL= AP YEAR= 2015 NEWMOLECULARENTITY
NDA 215260 (pdf not found) INN (SUGAMMADEX) SUGAMMADEX (TAMARANG SA) APPROVAL= TA YEAR= 2021
NDA 214319 (pdf not found) INN (SUGAMMADEX) SUGAMMADEX (SUN PHARM INDS) APPROVAL= TA YEAR= 2022
NDA 214290 (pdf not found) INN (SUGAMMADEX SODIUM) SUGAMMADEX SODIUM (ZYDUS PHARMS) APPROVAL= AP YEAR= 2023 DISCONTINUED
NDA 214337 (pdf not found) INN (SUGAMMADEX SODIUM) SUGAMMADEX SODIUM (ASPIRO) APPROVAL= AP YEAR= 2023
NDA 215701 (pdf not found) INN (SUGAMMADEX SODIUM) SUGAMMADEX SODIUM (SHANDONG) APPROVAL= TA YEAR= 2023
NDA 213915 (pdf not found) INN (SUGAMMADEX) SUGAMMADEX (MYLAN PHARMS INC) APPROVAL= TA YEAR= 2024
NDA 214311 (pdf not found) INN (SUGAMMADEX) SUGAMMADEX (SANDOZ INC) APPROVAL= TA YEAR= 2025
NDA 214230 (pdf not found) INN (SUGAMMADEX) SUGAMMADEX (MANKIND PHARMA) APPROVAL= TA YEAR= 2025
NDA 214279 (pdf not found) INN (SUGAMMADEX SODIUM) SUGAMMADEX SODIUM (FISIOPHARMA) APPROVAL= AP YEAR= 2025
NDA 218727 (pdf not found) INN (SUGAMMADEX) SUGAMMADEX (HIKMA PHARMACEUTICALS USA INC) APPROVAL= TA YEAR= 2025

Other links:

PubChem
ChemicalProbes

U.S. repository of Clinical Trials

VigiAccess
SIDER side effects

ChemSynthesis
Patent@SureChEMBL